The bad ventricle--revascularization versus transplantation

Thorac Cardiovasc Surg. 2000 Feb;48(1):9-14. doi: 10.1055/s-2000-8888.

Abstract

Background: The proportion of patients with left-ventricular dysfunction (LVD) undergoing high risk revascularization is increasing. In this patient group, the perioperative risk is elevated because of the pre-existing pathophysiology. Detailed evaluation and interdisciplinary differential therapeutic considerations on the basis of the comparative benefit rationale, with cardiac transplantation alternative, is mandatory.

Methods: Among 7275 patients who underwent coronary artery bypass grafting between 1990 and 1998 in our institution, we found 51 patients who had had an ejection fraction <20%, and thus were candidates for transplantation (group CABG); these were compared with 163 patients who were listed for cardiac transplantation because of ischemic cardiomyopathy (group HTX). The survival analysis was performed on the basis of the intention-to-treat principle independent of subsequent transplantation.

Results: Both groups were comparable with regard to left-ventricular ejection fraction; pulmonary capillary wedge pressure and serum creatinine, but patients in the CAGB group were older (63+/-11 vs 56+/-8; p = 0.001) and included a higher percentage of women (m/f: 42/9 vs 152/11; p = 0.03). Nevertheless, there was a similar 1-year survival in both groups (group BP 71.9% vs group HTX 66.3%; p = ns). Looking at the CABG group, the internal thoracic artery was used in 36/51 patients, an intra-aortic balloon pump was used preoperatively in 26 patients, and intraoperatively in 6. Left-ventricular assist devices had to be inserted in three patients, extracorporeal membrane oxygenation once. Perioperative (30 day) survival was 88.2 %. An elevated preoperative serum creatinine and the nonusage of the internal thoracic artery predicted an adverse outcome. In the long-term course, the NYHA functional class improved in most cases from III preoperatively to I after 26 (2-66) months.

Conclusion: We conclude that patients with ischemic cardiomyopathy, viable myocardium, and graftable vessels can be revascularized with acceptable risk. Since for these patients a standby of mechanical circulatory support must be anticipated perioperatively, this infrastructure should be established within the center.

MeSH terms

  • Aged
  • Comorbidity
  • Contraindications
  • Coronary Artery Bypass* / mortality
  • Coronary Disease / blood
  • Coronary Disease / epidemiology
  • Coronary Disease / mortality
  • Coronary Disease / surgery*
  • Creatinine / blood
  • Female
  • Heart Failure / blood
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Heart Failure / surgery*
  • Heart Transplantation*
  • Heart-Assist Devices
  • Humans
  • Intra-Aortic Balloon Pumping
  • Male
  • Middle Aged
  • Pulmonary Wedge Pressure
  • Survival Analysis
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / surgery*

Substances

  • Creatinine